+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Long-term therapy with proton pump inhibitors is associated with decreased bone density



Long-term therapy with proton pump inhibitors is associated with decreased bone density



Medical Hypotheses 72(5): 608-609




(PDF emailed within 0-6 h: $19.90)

Accession: 054173088

Download citation: RISBibTeXText

PMID: 19217215

DOI: 10.1016/j.mehy.2009.01.003


Related references

Effect of long-term proton pump inhibitors on bone mineral density. La Tunisie Medicale 96(3): 193-197, 2018

Proton pump inhibitors do not induce change in bone mineral density in a long-term observational study. Evidence-Based Medicine 18(5): 192-193, 2014

Proton pump inhibitors: use, misuse and concerns about long-term therapy. Clinical Journal of Gastroenterology 4(2): 53-59, 2011

New paradigm of the GERB and long-term therapy with proton pump inhibitors. Eksperimental'naia i Klinicheskaia Gastroenterologiia 4): 53-58, 2007

The effects of long-term therapy with proton pump inhibitors on meal stimulated gastrin. Digestive and Liver Disease 46(2): 125-130, 2014

Does eradication of Helicobacter pylori reduce hypergastrinaemia during long term therapy with proton pump inhibitors?. East African Medical Journal 80(3): 150-153, 2003

Does eradication of Helicobacter pylori infection reduce hypergastrinema during long term therapy with proton pump inhibitors?. Turkish Journal of Gastroenterology 13(3): 159-163, 2005

Hyperparathyroidism Associated with Long-Term Proton Pump Inhibitors Independent of Concurrent Bisphosphonate Therapy in Elderly Adults. Journal of the American Geriatrics Society 63(10): 2070-2073, 2016

Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial. Alimentary Pharmacology & Therapeutics 24(6): 945-954, 2006

Long-term therapy of acid-dependent diseases with proton pump inhibitors and risk of colorectal cancer (literature review). Eksperimental'naia i Klinicheskaia Gastroenterologiia 4): 36-38, 2009

Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women. JAMA 259(21): 3137-3141, 1988

Long-Term L-Thyroxine Therapy Is Associated with Decreased Hip Bone Density in Premenopausal Women. Obstetric and Gynecologic Survey 44(2): 142-143, 1989

Decreased bone mass despite long-term estrogen replacement therapy in young women with Turner's syndrome and previously normal bone density. Fertility & Sterility 72(5): 896-899, 1999

Is long-term L-thyroxine therapy associated with decreased bone mineral density in children with hypothyroidism?. Acta Paediatrica Supplement (423): 147, 1997

Long term l thyroxine therapy is associated with decreased femoral neck bone density in premenopausal women. Clinical Research 35(3): 648, 1987